Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
IPA Quote, Financials, Valuation and Earnings
Last price:
$1.7600
Seasonality move
:
419.43%
Day range:
$1.7100 - $1.9848
52-week range:
$0.2700 - $2.3173
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.87x
P/B ratio:
4.59x
Volume:
1.4M
Avg. volume:
4.3M
1-year change:
91.21%
Market cap:
$79.6M
Revenue:
$18.2M
EPS (TTM):
-$1.17
Earnings Data
Next earnings date for IPA
Jul 29
2025
Most recent earnings per share
-$0.46
Missed by $0.46
(Mar 28/2025)
Consensus Estimate
--
(Mar 28/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IPA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 07/31/2025 | Q3 | $4.5M | -- | -- | -- | -- |
| 07/29/2025 | Q2 | $5.5M | -- | -- | -- | -- |
| 03/28/2025 | Q1 | $4.6M | $4.3M | -$0.46 | -- | -- |
| 12/10/2024 | Q4 | $4.7M | $4.5M | -$0.07 | -- | -- |
| 09/16/2024 | Q3 | $4.9M | $3.8M | -$0.11 | -- | -- |
| 07/29/2024 | Q2 | $4.8M | $4.8M | -$0.53 | -$0.09 | -$0.45 |
| 03/14/2024 | Q1 | $4.5M | $4.6M | -$0.07 | -$0.08 | $0.00 |
| 12/14/2023 | Q4 | $4.3M | $4.5M | -$0.07 | -$0.10 | $0.02 |
| 09/14/2023 | Q3 | $4M | $4.3M | -$0.10 | -$0.16 | $0.05 |
| 07/07/2023 | Q2 | $4.2M | $4.1M | -$0.15 | -$0.12 | -$0.04 |
| 03/16/2023 | Q1 | $4M | $3.8M | -$0.14 | -$0.12 | -$0.02 |
| 12/15/2022 | Q4 | -- | $3.9M | -$0.23 | -- | -- |
| 09/14/2022 | Q3 | -- | $3.6M | -$0.30 | -- | -- |
| 07/29/2022 | Q2 | -- | $4.1M | -$0.18 | -- | -- |
| 03/16/2022 | Q1 | -- | $3.8M | -$0.16 | -- | -- |
| 12/13/2021 | Q4 | -- | $3.8M | -$0.21 | -- | -- |
| 09/09/2021 | Q3 | -- | $3.7M | -$0.14 | -- | -- |
| 04/30/2021 | Q2 | -- | $3.9M | -$0.24 | -- | -- |
| 03/17/2021 | Q1 | -- | $3.5M | -$0.06 | -- | -- |
| 10/31/2020 | Q4 | -- | $3.6M | -$0.02 | -- | -- |
| 07/31/2020 | Q3 | -- | $2.8M | -$0.03 | -- | -- |
| 04/30/2020 | Q2 | -- | $3M | -$0.05 | -- | -- |
| 01/31/2020 | Q1 | -- | $3.1M | -$0.04 | -- | -- |
| 10/31/2019 | Q4 | -- | $2.4M | -$0.08 | -- | -- |
| 07/31/2019 | Q3 | -- | $2M | -$0.11 | -- | -- |
| 04/30/2019 | Q2 | -- | $2M | -$0.23 | -- | -- |
| 01/31/2019 | Q1 | -- | $2M | -$0.08 | -- | -- |
| 10/31/2018 | Q4 | -- | $2.1M | -$0.08 | -- | -- |
| 07/31/2018 | Q3 | -- | $2.2M | -$0.08 | -- | -- |
| 04/30/2018 | Q2 | -- | $1.4M | -$0.16 | -- | -- |
| 01/31/2018 | Q1 | -- | $1.4M | -$0.12 | -- | -- |
| 10/31/2017 | Q4 | -- | $1.1M | -$0.08 | -- | -- |
| 07/31/2017 | Q3 | -- | $447.2K | -$0.08 | -- | -- |
| 04/30/2017 | Q2 | -- | $446.9K | -$0.12 | -- | -- |
| 01/31/2017 | Q1 | -- | $383K | -$0.97 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.00 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.09 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.00 | -- | -- |
ImmunoPrecise Antibodies Earnings Questions
-
How Much did ImmunoPrecise Antibodies Generate in Revenue Last Quarter?
ImmunoPrecise Antibodies reported $4.3M worth of top line sales in its most recent quarter.
-
Did ImmunoPrecise Antibodies Beat Earnings Last Quarter?
ImmunoPrecise Antibodies announced earnings per share of -$0.46 which represents a miss of analyst forecast a -- per share.
-
Is ImmunoPrecise Antibodies Profitable?
ImmunoPrecise Antibodies reported $2.3M that represents $0.07 per share over the last quarter.
-
What is the Analyst Consensus for ImmunoPrecise Antibodies EPS Next Year?
ImmunoPrecise Antibodies's earnings are forecast to decrease from -$0.78 per share to -$0.35 per share next year representing a decrease of -56.32%.
-
When is ImmunoPrecise Antibodies's Earnings Date?
ImmunoPrecise Antibodies's next earnings date is July 29, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.16% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 10.79% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 5.29% over the past day.
